Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole-Reference-Cited by-同舟云学术

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole

Published:2020-11-10 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Freitas Raíza Dias,Dias Rosane Borges,Vidal Manuela Torres Andion,Valverde Ludmila de Faro,Gomes Alves Costa Rafaela,Damasceno Andresa Karen Andrade,Sales Caroline Brandi Schlaepfer,Siquara da Rocha Leonardo de Oliveira,dos Reis Mitermayer Galvão,Soares Milena Botelho Pereira,Coletta Ricardo Della,Pereira Thiago Almeida,Bezerra Daniel Pereira,Gurgel Rocha Clarissa Araújo

Funder

Fundação de Amparo à Pesquisa do Estado da Bahia

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference74 articles.

1. Histological and molecular aspects of oral squamous cell carcinoma (Review);Rivera;Oncol Lett,2014

2. Oral Cavity and Oropharyngeal Squamous Cell Carcinoma—An Update. CA;Chi;Cancer J Clin,2015

3. Oral and oropharyngeal cancer: epidemiology and survival analysis;Moro;Einstein (São Paulo),2018

4. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2018

5. Global cancer statistics;Jemal;CA Cancer J Clin,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary cilia-associated signalling in squamous cell carcinoma of head and neck region;Frontiers in Oncology;2024-08-21

2. New insights into RAS in head and neck cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

3. Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies;Signal Transduction and Targeted Therapy;2023-08-18

4. The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma;Cells;2023-08-17

5. Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells;International Journal of Molecular Sciences;2023-06-21